Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Therapeutic Drug Carrier Systems
Impact-faktor: 2.9 5-jähriger Impact-Faktor: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN Druckformat: 0743-4863
ISSN Online: 2162-660X

Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v29.i1.20
pages 65-88

Two Faces of Carbon Nanotube: Toxicities and Pharmaceutical Applications

Neha Gulati
School of Pharmacy, Bharat Institute of Technology, Meerut, UP, India
Himanshu Gupta
Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India


In the field of nanotechnology, carbon nanotube (CNT) is gaining importance for the delivery of therapeutic agents and diagnosis of diseases. CNT is emerging as an efficient nanocarrier system with cylindrical nanostructure. Due to its nanoscale dimensions, CNTs have a high cell-penetration quality that allows its use in site-specific targeting. Another aspect of the utilization of CNT lies in its hollow structure through which an active moiety can be delivered in a controlled manner via CNTs' nano channels. Despite these positive aspects of CNT, scientists are still working to improve its biocompatibility and solubility and eliminating toxicity in vivo, which are creating problems with the use of CNTs. Therefore, functionalization becomes an important aspect to be studied because it decreases the toxicity of CNTs and make them nonimmunogenic. In this review, different functionalization techniques of CNTs and their biomedical applications−in particular for cancer therapy to date−are reviewed in detail to present the potential of this nanovector.

Articles with similar content:

Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 6
Eliahu Heldman, Kristin Loomis, Brandon Smith, Anu Puri, Jae-Ho Lee, Amichai Yavlovich, Robert Blumenthal
Solid Lipid Nanoparticles: Vital Characteristics and Prospective Applications in Cancer Treatment
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.36, 2019, issue 6
Lucia R. Tefas, Diana Tudor, Elena Diana Olteanu, Marcela Achim, Claudia Burz, Iuliana Nenu, Gabriela Adriana Filip, Ioana Baldea, Leontin F. Lazăr, Simona Clichici, Radu Iuga
Nanoscience and Technology: An International Journal, Vol.5, 2014, issue 1
V. I. Karandin, A. G. Rozhkov, A. N. Danilin, Yuri G. Yanovsky, Yulia N. Karnet
Pharmaceutical and Biomedical Potential of Surface Engineered Dendrimers
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.24, 2007, issue 3
Narendra Kumar Jain, Umesh Gupta, Jitendra Satija
Application of Hydrogels in Heart Valve Tissue Engineering
Journal of Long-Term Effects of Medical Implants, Vol.25, 2015, issue 1-2
Bin Xu, Daniel S. Puperi, Xing Zhang, K. Jane Grande-Allen, Yan Wu, Jennifer L. West